Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2025-12-31 @ 8:19 PM
Study NCT ID:
NCT04772235
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2021-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients
Sponsor:
Instituto Oncológico Dr Rosell
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
IOR-TPT-IST-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |